Structural alterations in small resistance arteries in obesity

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 1, 2012, Pages 56-62

  Rizzoni, Damiano ^a   De Ciuceis, Carolina ^a   Porteri, Enzo ^a   Semeraro, Francesco ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT;

ANGIOGENESIS; ARTERY; ARTERY MEDIA; BIOMECHANICS; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; HYPERTROPHIC REMODELLING; HYPERTROPHY; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RESISTANCE BLOOD VESSEL; SHORT SURVEY; SUBCUTANEOUS SMALL ARTERY; TISSUE STRUCTURE; VASODILATATION; WEIGHT REDUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOLES; HUMANS; HYPERTENSION; MECHANICAL PHENOMENA; MUSCLE, SMOOTH, VASCULAR; OBESITY; SUBCUTANEOUS TISSUE; VASCULAR RESISTANCE;

EID: 83455193277     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00786.x     Document Type: Short Survey

References (50)

1. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990;70:921-71.
2. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004;17(12 Pt 1):1192-200.
3. Heagerty AM. Predicting hypertension complications from small artery structure. J Hypertens 2007;25:939-40.
4. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME et al. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008;118:968-76.
5. Agabiti Rosei E, Rizzoni D. The effects of hypertension on the structure of human resistance arteries. In: Lip GYH, Hall JE (eds). Comprehensive Hypertension, Chapter 47. Mosby Elsevier, Amsterdam, 2007, 579-90.
6. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996;28:785-90.
7. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non insulin dependent diabetes mellitus. Circulation 2001;103:1238-44.
8. Greenstein AS, Price A, Sonoyama K, Paisley A, Khavandi K, Withers S et al. Eutrophic remodeling of small arteries in type 1 diabetes mellitus is enabled by metabolic control: a 10-year follow-up study. Hypertension 2009;54:134-41.
9. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993;21:391-7.
10. Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari GE, Mortini P et al. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens 2009;27:838-45.
11. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002;17:105-9.
12. Heerkens EH, Izzard AS, Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension 2007;49:1-4.
13. Touyz RM. Molecular and cellular mechanisms regulating vascular function and structure-implications in the pathogenesis of hypertension. Can J Cardiol 2000;16:1137-46.
14. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38(3 Pt 2):581-7.
15. Rizzoni D, Porteri E, Giustina A, De Ciuceis C, Sleiman I, Boari GE et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 2004;43:561-5.
16. Schofield I, Malik R, Izzard A, Austin C, Heagerty AM. Vascular structural and functional changes in type 2 diabetes mellitus. Evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002;106:3037-43.
17. Rizzoni D, Porteri E, Boari GEM, De Ciuceis C, Sleiman I, Muiesan ML et al. Prognostic significance of small artery structure in hypertension. Circulation 2003;108:2230-5.
18. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Mørn B, Schroeder AP et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007;25:1021-6.
19. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GEM et al. Structural alterations of subcutaneous small arteries may predict major cardiovascular events in hypertensive patients. Am J Hypertens 2007;20:846-52.
20. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005;23:247-50.
21. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G et al. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003;21:625-32.
22. Touyz RM, Savoia C, He Y, Endemann D, Pu Q, Ko EA et al. Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade. J Am Soc Hypertens 2007;1:189-99.
23. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010;6:71-82.
24. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009;276:5747-54.
25. Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010;20:72-7.
26. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens 2009;27:1107-14.
27. Grassi G, Seravalle G, Scopelliti F, Dell'Oro R, Fattori L, Quarti-Trevano F et al. Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity. Obesity (Silver Spring) 2010;18:92-8.
28. Grassi G, Seravalle G, Brambilla G, Facchetti R, Bolla G, Mozzi E et al. Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients. J Hypertens 2010;28:1708-14.
29. De Ciuceis C, Porteri E, Rizzoni D, Corbellini C, La Boria E, Boari GEM et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension 2011;58:29-36.
30. Grassi G, Diez J. Obesity-related cardiac and vascular structural alterations: beyond blood pressure overload. J Hypertens 2009;27:1750-2.
31. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007;112:375-84.
32. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-10.
33. De Ciuceis C, Rizzoni D, Porteri E, Boari GE, Zani F, Miclini M et al. Effects of insulin on endothelial and contractile function of subcutaneous small resistance arteries of hypertensive and diabetic patients. J Vasc Res 2008;45:512-20.
34. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-904.
35. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005;48:1359-65.
36. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004;44:847-52.
37. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009;54:690-7.
38. Rizzoni D, Agabiti Rosei E. Small artery remodeling in diabetes mellitus. Nutr Metab Cardiovasc Dis 2009;19:587-92.
39. Paiardi S, Rodella LF, De Ciuceis C, Porteri E, Boari GE, Rezzani R et al. Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc 2009;42:259-68.
40. Frisbee JC. Obesity, insulin resistance, and microvessel density. Microcirculation 2007;14:289-98.
41. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-7.
42. Ferreira I, Twisk JW, Van Mechelen W, Kemper HC, Seidell JC, Stehouwer CD. Current and adolescent body fatness and fat distribution: relationships with carotid intima-media thickness and large artery stiffness at the age of 36years. J Hypertens 2004;22:145-55.
43. Ferreira I, Henry RM, Twisk JW, Van Mechelen W, Kemper HC, Stehouwer CD et al. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 2005;165:875-82.
44. Zebekakis PE, Nawrot T, Thijs L, Balkestein EJ, van der Heijden-Spek J, Van Bortel LM et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005;23:1839-46.
45. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999;33:569-74.
46. Savoia C, Touyz RM, Endemann DH, Pu Q, Ko EA, De Ciuceis C et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006;48:271-7.
47. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008;51:432-9.
48. Czernichow S, Bertrais S, Blacher J, Oppert JM, Galan P, Ducimetière P et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study. Am J Hypertens 2005;18:1154-60.
49. Toledo-Corral CM, Ventura EE, Hodis HN, Weigensberg MJ, Lane CJ, Li Y et al. Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children. Atherosclerosis 2009;206:594-8.
50. Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L et al. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2008;51:440-5.